Abstract
Anthracyclines are chemotherapeutic agents widely used in the treatment of hematologic malignancies and cancer. Among these, doxorubicin (DOXO) takes a prominent position. It is worth mentioning, however, that this alternative therapy can cause cellular damage of great magnitude, particularly in cardiomyocytes, persisting even after the duration of drug use. In these cases, the advance fo…